- Phase I
- Phase II/III
- Therapeutic expertise
- Rescue services
- Technology solutions
- Comprehensive capabilities
- News &
Clinical Research Operations and Management Support (CROMS) for the National Institute of Dental and Craniofacial Research (NIDCR)
Building the infrastructure and providing full-scope research services for groundbreaking studies of oral, dental, and craniofacial diseases and disorders
Through the Clinical Research Operations and Management Support (CROMS) contract with the National Institute of Dental and Craniofacial Research (NIDCR), Rho provides comprehensive research support services to a variety of clinical studies. The NIDCR supports clinical research on the cause, incidence, prevalence, prevention, and treatment of oral, dental, and craniofacial diseases and disorders.
On a per-study basis, Rho support includes one or more of the following services: protocol design/development; project and site management; regulatory consulting and management; clinical research operations and study monitoring; data management; safety management; biostatistics; and manuscript and regulatory document preparation. In addition to study-specific operational support, Rho has collaborated in the development of an extensive Clinical Research Toolkit to facilitate all aspects of clinical research. Rho also provides a secure program website that is accessible by all NIDCR staff and NIDCR funded research teams. The website includes dynamic announcements; staff directories; calendars; study and committee areas for document storage, access, and reporting; document versioning tools; grant and study level data collection and software for portfolio management, reporting, and analysis.
The CROMS group at Rho is led by Dr. Nancy Yovetich, Principal Investigator, and Cathie Snyder, Program Director.
For more information about NIDCR CROMS studies, please see below.
|NCT01316770||Alevizos 11-D-0094: Parotid Irrigation||Dexamethasone Irrigation of the Parotid Glands in Primary Sjogren's Syndrome Subjects|
|NCT00395538||Gafni 07-D-0016: PTH||Effects of PTH Replacement on Bone in Hypoparathyroidism|
|NCT01078467||Gutkind 10-D-0020: OWH||The Molecular Anatomy of Oral Wound Healing|
|NCT01195922||Gutkind 10-D-0180: mTOR||Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma|
|NCT00804154||Heiss 09-D-0039: RTX||Resiniferatoxin to Treat Severe Pain Associated with Advanced Cancer|
|NCT01568697||Moutsopoulos 12-D-0100: Oral Micro||Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)|
|NCT01489839||Teles 10-174-E: Biomarkers of PDP||Biomarkers of Periodontal Disease Progression|
|N/A||Gafni T-D-0030: Cinacalcet||Open-label Dose-titration Study of the Tolerability and Efficacy of Cinacalcet to Treat Fibroblast Growth Factor 23 (FGF-23)-mediated Hypophosphatemia|
|N/A||Alevizos 06-D-0206: AdhAQP1||Open-label, Dose-escalation Study Evaluating the Safety of a Single Administration of an Adrenoviral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in Individuals with Irradiation-induced Parotid Salivary Hypofunction|
|N/A||McDevitt 09-018-E: AMI||Development of a Lab-on-a-chip System for Saliva-based Diagnostics|
|N/A||McDevitt 09-020-E: OSCC||Characterization of Suspicious Oral LESIONS Using Novel Lab-on-a-chip Ensembles|